ACUTE EFFECTS OF EXERCISE ON POST-PRANDIAL ACTIVITY OF DIPEPTIDYL PEPTIDASE-4 IN TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Sousa, N. M. [1 ]
Silva, L. R. [1 ]
Barros, F. C. [1 ]
Fraga, M. Z. [1 ]
Coelho, B. [2 ]
Silva Filho, W. G. [2 ]
Barauna, V. G. [2 ]
机构：
[1] Fac Estacio Sa, Lab Exercise Physiol, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Lab Mol & Cellular Physiol, Vitoria, ES, Brazil
来源：
CARDIOLOGY | 2017年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
308
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [31] Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Akaike, Masashi
    Fukuda, Daiju
    Salim, Hotimah Masdan
    Ishida, Masayoshi
    Matsuura, Tomomi
    Ise, Takayuki
    Yamaguchi, Koji
    Iwase, Takashi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Matsumoto, Toshio
    Sata, Masataka
    [J]. DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 342 - 347
  • [32] Potential Impact of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Pathophysiology in Type 2 Diabetes Mellitus
    Davidson, Michael H.
    [J]. POSTGRADUATE MEDICINE, 2014, 126 (03) : 56 - 65
  • [33] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Xin Wei
    Yu Bai
    Zhuo Wang
    Xiaohong Zheng
    Zening Jin
    Xin Liu
    [J]. Diabetology & Metabolic Syndrome, 13
  • [34] EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR SITAGLIPTIN IN OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS
    Stafford, Sara
    Elahi, Dariush
    Meneilly, Graydon S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (06) : 1148 - 1149
  • [35] Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Li, Ning
    Wang, Li-Jun
    Jiang, Bo
    Li, Xiang-qian
    Guo, Chuan-long
    Guo, Shu-ju
    Shi, Da-Yong
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 145 - 157
  • [36] The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
    Susana Ravassa
    Joaquín Barba
    Isabel Coma-Canella
    Ana Huerta
    Begoña López
    Arantxa González
    Javier Díez
    [J]. Cardiovascular Diabetology, 12
  • [37] The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
    Ravassa, Susana
    Barba, Joaquin
    Coma-Canella, Isabel
    Huerta, Ana
    Lopez, Begona
    Gonzalez, Arantxa
    Diez, Javier
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [38] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    [J]. JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [39] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [40] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    [J]. PharmacoEconomics, 2015, 33 : 581 - 597
12345